Tetramethrin - Environmental Health Criteria 98
| dc.contributor | Economy Division | en_US |
| dc.contributor.author | United Nations Environment Programme | en_US |
| dc.contributor.author | World Health Organization | en_US |
| dc.contributor.author | International Labour Organisation | en_US |
| dc.coverage.spatial | Global | en_US |
| dc.date.accessioned | 2019-08-15T17:07:25Z | |
| dc.date.available | 2019-08-15T17:07:25Z | |
| dc.date.issued | 1990 | |
| dc.identifier.isbn | 92 4 154298 5 | en_US |
| dc.identifier.uri | https://wedocs.unep.org/20.500.11822/29410 | |
| dc.description | Tetramethrin was first synthesized in 1964 and first marketed in 1965. Chemically, it is an ester of chrysan-themic acid (2,2-imethyl-3-(2,2-dimethylvinyl)-cyclopro-panecarboxylic acid) with 3,4,5,6-tetrahydrophthalimido-methyl alcohol. It is a mixture of four stereoisomers:[1R,trans], [1R,cis], [1S,trans], and [1S,cis]. In techni-cal products, the composition ratio of the isomers is roughly 4:1:4:1. Among the isomers, the [1R,trans] isomer is the most active biologically followed by the [1R,cis] isomer. A mixture of the [1R,cis] and [1R,trans] isomers (1:4) is commercialized under the trade name of `Neo-Pynamin Forte' (designated as 1R, cis/trans-tetramethrin in this monograph). | en_US |
| dc.format | Text | en_US |
| dc.language | English | en_US |
| dc.rights | Public | en_US |
| dc.subject | environmental health | en_US |
| dc.subject | chemical | en_US |
| dc.subject | aquatic ecology | en_US |
| dc.subject | terrestrial ecosystem | en_US |
| dc.title | Tetramethrin - Environmental Health Criteria 98 | en_US |
| wd.identifier.sdg | SDG 3 - Good Health and Well-being | en_US |
| wd.topics | Chemicals and Pollution Action | en_US |
| wd.identifier.pagesnumber | 72 pages | en_US |
